
1. malar j. 2019 aug 23;18(1):285. doi: 10.1186/s12936-019-2916-6.

are k13 plasmepsin ii genes, involved plasmodium falciparum resistance 
artemisinin derivatives piperaquine southeast asia, reliable monitor
resistance surveillance africa?

foguim tsombeng f(1)(2)(3), gendrot m(1)(2)(3), robert mg(1)(2)(3), madamet
m(1)(2)(3)(4), pradines b(5)(6)(7)(8).

author information: 
(1)unité parasitologie et entomologie, département microbiologie et maladies
infectieuses, institut de recherche biomédicale des armées, 19-21 boulevard jean 
moulin, 13005, marseille, france.
(2)aix marseille univ, ird, ssa, ap-hm, vitrome, marseille, france.
(3)ihu méditerranée infection, marseille, france.
(4)centre national de référence du paludisme, institut de recherche biomédicale
des armées, marseille, france.
(5)unité parasitologie et entomologie, département microbiologie et maladies
infectieuses, institut de recherche biomédicale des armées, 19-21 boulevard jean 
moulin, 13005, marseille, france. bruno.pradines@gmail.com.
(6)aix marseille univ, ird, ssa, ap-hm, vitrome, marseille, france.
bruno.pradines@gmail.com.
(7)ihu méditerranée infection, marseille, france. bruno.pradines@gmail.com.
(8)centre national de référence du paludisme, institut de recherche biomédicale
des armées, marseille, france. bruno.pradines@gmail.com.

mutations propeller domain plasmodium falciparum kelch 13 (pfk13) gene 
are associated artemisinin resistance southeast asia. artemisinin
resistance defined increased ring survival rate delayed parasite
clearance half-life patients. additionally, amplification plasmodium
falciparum plasmepsin ii gene (pfpm2), encoding protease involved hemoglobin
degradation, found associated reduced vitro susceptibility
to piperaquine cambodian p. falciparum parasites with
dihydroartemisinin-piperaquine failures cambodia. world health
organization (who) recommended use two genes track the
emergence spread resistance dihydroartemisinin-piperaquine in
malaria endemic areas. although resistance dihydroartemisinin-piperaquine 
has yet emerged africa, reports clinical failures suggest k13 
and pfpm2 would genes involved artemisinin piperaquine
resistance. imperative identify molecular markers drug resistance
genes associate artemisinin piperaquine africa. k13
polymorphisms pfpm2 copy number variation analysis may sufficient 
monitoring emergence dihydroartemisinin-piperaquine resistance africa. 
but, markers ruled tracking emergence of
resistance.

doi: 10.1186/s12936-019-2916-6 
pmcid: pmc6708145
pmid: 31443646  [indexed medline]

